评估乳腺X线摄影筛查有效性:2015年IARC建议需要修订
该观点文章基于一项观察性研究的系统综述,发现参加乳腺X线摄影筛查者相比从不参加者,乳腺癌死亡风险降低45%(95%CI:40-50%),非乳腺癌死亡风险降低46%(95%CI:42-50%)。作者认为参加筛查是个人特征的标志,与任何原因死亡风险较低相关,观察性研究将其误读为筛查效应,因此对IARC 2015年建议提出质疑,并主张恢复IARC 2002年基于描述性和比较性研究的建议。
要点
- 参加筛查者相比从不参加者乳腺癌死亡风险降低45%(95%CI:40-50%),非乳腺癌死亡风险降低46%(95%CI:42-50%)。
- 筛查乳腺X线摄影对非乳腺癌死因无已知有益影响。
- 作者认为参加筛查是个人特征的标志,与任何原因死亡风险较低相关,观察性研究误读为筛查效应。
核心结论
- 本文对IARC 2015年建议提出质疑,并主张恢复IARC 2002年基于描述性和比较性研究的建议。
研究设计与样本
- 本文为观点文章,基于一项观察性研究的系统综述。
主要发现
- 参加筛查者相比从不参加者,乳腺癌死亡风险降低45%(95%CI:40-50%)。
- 参加筛查者相比从不参加者,非乳腺癌死亡风险降低46%(95%CI:42-50%)。
- 筛查乳腺X线摄影对非乳腺癌死因无已知有益影响。
- 作者认为参加筛查是个人特征的标志,与任何原因死亡风险较低相关,观察性研究将其误读为筛查效应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Breast cancer screening effectiveness is measured by its ability to reduce breast cancer mortality in real world settings. A viewpoint issued by the International Agency for Research on Cancer (IARC) in 2015 considered that observational studies (cohort and case-control) are the preferred methods to evaluate the effectiveness of mammography screening. A statistical method was deemed to correct for differences in personal characteristics between women choosing to attend or to not attend screening (self-selection bias). But we showed in a systematic review of observational studies that, compared to women who never attend screening, attenders have a 45 % reduction in their risk of breast cancer death (95 % CI: 40-50 %) and a 46 % reduction (95 % CI: 42-50 %) in their risk of death from a cause other than breast cancer. Screening mammography has no known beneficial influence on causes of death other than breast cancer. If screening mammography reduced the risk of breast cancer death, one would expect a much greater percentage reduction in the risk of breast cancer death than in the risk of all-cause death. Our results suggest that screening mammography attendance is an indicator of personal characteristics associated with a lower risk of dying from any cause, including from breast cancer, which observational studies have misinterpreted as a screening effect. This paper calls into question the IARC 2015 recommendations and advocates the reinstatement of recommendations made by the IARC in 2002 which were based on the use of descriptive and comparative studies.
引用
- Autier P, Jørgensen KJ, Støvring H, et al. Evaluation of screening mammography effectiveness: The IARC recommendations of 2015 need revision. Eur J Cancer. 2025. PMID: 40712255. doi:10.1016/j.ejca.2025.115657
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。